Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: A pharmacokinetic study

BMJ Open

Volumn 3, Issue 5, 2013, Pages

  Rao, A ^a   Standing, J F ^b   Naik, S ^a   Savage, M O ^a   Sanderson, I R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SOMATOMEDIN C;

ARTICLE; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GROWTH DISORDER; HUMAN; INTERVENTION STUDY; MALE; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 84878389842     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002737     Document Type: Article

References (43)

1. Sawczenko A, Sandhu BK, Logan RF, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4. (Pubitemid 32322542)
2. Lowe AM, Roy O, B-Poulin M, et al. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis 2009;15:429-35.
3. Henderson P, Hansen R, Cameron FL, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012;18:999-1005.
4. Shamir R, Phillip M, Levine A. Growth retardation in pediatric Crohn's disease: pathogenesis and interventions. Inflamm Bowel Dis 2007;13:620-8. (Pubitemid 46799646)
5. Thomas MJ. The molecular basis of growth hormone action. Growth Horm IGF Res 1998;8:3-11. (Pubitemid 29132913)
6. Thomas AG, Holly JM, Taylor F, et al. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993;34:944-7. (Pubitemid 23203117)
7. Bannerjee K, Camacho-Hübner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
8. Ballinger AB, Azooz O, El-Haj T, et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000;46:694-700. (Pubitemid 30305788)
9. Sawczenko A, Azooz O, Paraszczuk J, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the-174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A 2005;102:13260-5. (Pubitemid 41325011)
10. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-50. (Pubitemid 27097665)
11. Denson LA, Held MA, Menon RK, et al. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol 2003;284:G646-54. (Pubitemid 36343214)
12. Chernausek SD, Backeljauw PF, Frane J, et al. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 2007;92:902-10. (Pubitemid 46465661)
13. Jenkins PJ, Frajese V, Jones AM, et al. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 2000;85:3218-21.
14. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
15. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
16. Hyams J, Ferry GD, Mandel FS, et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005;41:416-21. (Pubitemid 41407602)
17. Beal S, Steven LB, Boeckmann A, et al. NONMEM. Ellicott City, MD: Icon Development Solutions, 1989-2009.
18. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008;48:303-32. (Pubitemid 351738156)
19. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat 1979;7:1-26.
20. Newby EA, Sawczenko A, Thomas AG, et al. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev 2005(3):CD003873.
21. Sawczenko A, Ballinger AB, Croft NM, et al. Adult height in patients with early onset of Crohn's disease. Gut 2003;52:454-5; author reply 455. (Pubitemid 36250073)
22. Pfefferkorn M, Burke G, Griffiths A, et al. Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr 2009;48:168-74.
23. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997;336:633-40.
24. Beeken WL, Busch HJ, Sylwester DL. Intestinal protein loss in Crohn's disease. Gastroenterology 1972;62:207-15.
25. Ferrante M, Penninckx F, De Hertogh G, et al. Protein-losing enteropathy in Crohn's disease. Acta Gastroenterol Belg 2006;69:384-9.
26. Karbach U, Ewe K, Bodenstein H. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983;24:718-23. (Pubitemid 13030237)
27. Savage MO, Blum WF, Ranke MB, et al. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993;77:1465-71. (Pubitemid 24000897)
28. Jenkins PJ. Acromegaly and colon cancer. Growth Horm IGF Res 2000;10(Suppl A):S35-6. (Pubitemid 30641928)
29. Sobel EH, Silverman FN, Lee CM Jr. Chronic regional enteritis and growth retardation. Am J Dis Child 1962;103:569-76.
30. Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986;91:830-6. (Pubitemid 16014587)
31. Lipson AB, Savage MO, Davies PS, et al. Acceleration of linear growth following intestinal resection for Crohn disease. Eur J Pediatr 1990;149:687-90. (Pubitemid 20220989)
32. Borrelli O, Bascietto C, Viola F, et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 2004;36:342-7. (Pubitemid 41115465)
33. Walters TD, Gilman AR, Griffiths AM. Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis 2007;13:424-30. (Pubitemid 46668247)
34. Sanderson IR, Boulton P, Menzies I, et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987;62:123-7. (Pubitemid 17004189)
35. Heyman MB, Garnett EA, Wojcicki J, et al. Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. J Pediatr 2008;153:651-8, 658 e1-3.
36. Denson LA, Kim MO, Bezold R, et al. A randomized controlled trial of growth hormone in active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 51:130-9.
37. Sanderson IR, Udeen S, Davies PS, et al. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 1987;28:1073-6. (Pubitemid 17154467)
38. Teahon K, Smethurst P, Levi AJ, et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33:320-3.
39. Fries W, Muja C, Crisafulli C, et al. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am J Physiol Gastrointest Liver Physiol 2008;294: G938-47. (Pubitemid 351520063)
40. Rabkin R, Fervenza FC, Maidment H, et al. Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure. Kidney Int 1996;49:1134-40. (Pubitemid 26122717)
41. Fouque D, Peng SC, Kopple JD. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. Kidney Int 1995;47:869-75.
42. Jonsson S, Karlsson MO. A rational approach for selection of optimal covariate-based dosing strategies. Clin Pharmacol Ther 2003;73:7-19. (Pubitemid 36158482)
43. Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 18:55-62.